MétaCan
Menu
← Back to cohort

Clinical presentation and outcomes after surgery for mitral regurgitation - Real world insights from the MITRACURE international registry

2025· article· en· W7127634202 on OpenAlexaffabout
D Messika-Zeitoun, M W A Chu, D Bouchard, T Le Tourneau, Julien Ternacle, J C Dib, C Lam, A Anselmi, O Brault Meslin, A Goutondji, Y Lavie-Badie, W Kent, B Iung, J F Obadia, J Dreyfus

Bibliographic record

VenueEuropean Heart Journal · 2025
Typearticle
Languageen
FieldMedicine
TopicCardiac Valve Diseases and Treatments
Canadian institutionsUniversity of CalgaryMontreal Heart InstituteWestern UniversityUniversity of British ColumbiaOttawa Heart Institute
Fundersnot available
KeywordsMitral regurgitationMitral valveStenosisPresentation (obstetrics)Infective endocarditisHeart failureEjection fractionEtiology

Abstract

fetched live from OpenAlex

Abstract Background/Introduction Detailed information on the clinical presentation, contemporary management, and outcomes of all-comer patients referred for mitral valve surgery (MVS) is critical to evaluating current practice, assessing adherence to guidelines, understanding selection biases, and informing key stakeholders about areas for improvement. Purpose The MITRACURE registry aims to provide a real-world, multicenter perspective on MVS for mitral regurgitation (MR) in France and Canada, focusing on patient characteristics, treatment patterns, and early outcomes. Methods MITRACURE is a large international retrospective registry of consecutive adult patients who underwent MVS, combined or isolated, for MR in France and in Canada in 2019, with in-depth clinical and echocardiographic characterization. Patients operated on for isolated mitral stenosis or who had a prior mitral valve intervention were excluded. Data were obtained from detailed chart abstraction and were site reported. Results A total of 3,522 patients underwent MVS (48% combined) across 40 centers (88±46 MVS/center, median 80, IQ[51-131]). Mean age was 65±12 years and 35% were female. Most common MR etiology was myxomatous (61%), followed by functional (9%), infective endocarditis (9%) and rheumatic disease (7%). MR quantification was performed in only 43%. Advanced clinical presentation was common: 43% were in NYHA class III/IV, 30% exhibited congestive heart failure, 47% were on diuretics, 22% in atrial fibrillation/flutter, 35% presented with reduced ejection fraction and 22% with pulmonary hypertension (≥50 mmHg). Most patients were either symptomatic or presented a class I/IIa indication for intervention and an early intervention was only performed in 3% of the population. Repair rate was 62% overall, 80% in myxomatous disease. In-hospital mortality was 4.5% overall, 2.3% in patients with myxomatous valve (1.8% and 3.1% for isolated and combined MVS respectively) (Figure). Conclusion(s) MITRACURE provides a contemporary, multicenter real-world picture of the clinical presentation, management and in-hospital outcomes of MVS for MR in two Western countries. Patients were often referred late in the course of the disease, and only a few underwent an early intervention. Mortality rates were substantial, and repair rates have room for further improvement. Our results underline the need to develop strategies to improve management and outcomes of patients with MR.Figure

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.009
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.022
Threshold uncertainty score0.044

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.009
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0030.004
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.048
GPT teacher head0.421
Teacher spread0.373 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueEuropean Heart Journal→Same topicCardiac Valve Diseases and Treatments→French-language works237,207→